Current Issue

Clinical Genitourinary Cancer

April 2023Volume 21Issue 2

Current Issue Links

• Articles in Press
• Past Issues

Submit Mobile

• Submit article

Explore

• Subscribe
• Editorial Board
• Elsevier's Oncology Journal Network
   
• Researcher Academy
   

Publish

• Submit Article
   
• Aims and Scope
• For Authors
• Supports Open Access
   

Connect

• Alerts
• Activate Online Access
   
• Career Opportunities
   
• CLCC
   
• CLML
   

Articles in Press

• 
  Original Study OSA

  Expression of RSUME is associated with poor prognosis in clear cell Renal Carcinoma: involvement of ROS related metabolism

  Gonilski-Pacin et al.

  Published online: March 23, 2023
• 
  Original Study

  Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix vs Leuprolide in Men with Advanced Prostate Cancer

  George et al.

  Published online: March 23, 2023
• 
  Original Study

  Single-dose post-office fulguration mitomycin C instillation appears to improve recurrence-free survival in patients with low-grade non-invasive bladder cancer

  Halstuch et al.

  Published online: March 22, 2023
• 
  Original Study Original StudyDoc head & section head both text are the same. please check

  Variations in penile cancer management: Results from the Global Society of Rare Genitourinary Tumors Survey

  Prakash et al.

  Published online: March 20, 2023

View All

Issue Highlights

• 

  Assessment of Tolerability, Response and Complications of Concurrent Chemoradiation With Capecitabine and Cisplatin in Muscle-Invasive Bladder Cancer; A Single Arm Study

  Sara Soltanzadeh, Arefeh Saeedian, Reza Ghalehtaki, Mohsen Ayati, Mohammadreza Nowroozi, Peiman Haddad, Mahdieh Shafiee Sabet, Amin Kheirolahi

• 

  CABOSEQ: The Effectiveness of Cabozantinib in Patients With Treatment Refractory Advanced Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)

  Vishal Navani, J Connor Wells, Devon J Boyne, Winson Y Cheung, Darren M Brenner, Bradley A McGregor, Chris Labaki, Andrew L Schmidt, Rana R McKay, Luis Meza, Sumanta K Pal, Frede Donskov, Benoit Beuselinck, Maxwell Otiato, Lisa Ludwig, Thomas Powles, Bernadett E Szabados, Toni K Choueiri, Daniel Y C Heng

• 

  Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden

  Pär Stattin, Marcus Westerberg, Ingela Franck Lissbrant, Marie Hjälm Eriksson, Anders Kjellman, Anders Ullén, Zdravko Vassilev, Per Sandstrom, Rachel Weinrib, David Martinez, Xabier Garcia-Albeniz

About

Clinical Genitourinary Cancer

Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research in genitourinary cancers. Clinical Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary malignancies. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

more

Companion Journals

Metrics

Metrics

##

Impact Factor

##

5-Year Impact Factor

5.0

CiteScore

• More Journal Metrics
   
• Submit a Manuscript
   
• Top Social Media Articles
   

Co-Editors-in-Chief

Leonard Appleman, MD, Pittsburgh, Pennsylvania, United States of America

Matthew Milowsky, Chapel Hill, North Carolina, United States of America

 

Attention Qualified Recipients

If you are a qualified recipient of the US print edition of Clinical Genitourinary Cancer, click here to access the online edition.

Most Read (Last 30 Days)

• 
  Original Study

  Open Access

  Treatment Patterns and Outcomes in Stage IV Bladder Cancer in a Community Oncology Setting: 2008-2015

  Fisher et al.

  Published online: August 10, 2018
• 
  Original Study

  Open Access

  Urinary Neuroendocrine Neoplasms Treated in the “Modern Era”: A Multicenter Retrospective Review

  Le et al.

  Published online: March 16, 2023
• Original Study

  Open Access

  Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma

  Makrakis et al.

  Published online: November 13, 2022
• 
  Original Study

  Open Access

  CABOSEQ: The Effectiveness of Cabozantinib in Patients With Treatment Refractory Advanced Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)

  Navani et al.

  Published online: July 20, 2022
• 
  Original Study

  Open Access

  Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United States

  George et al.

  Published online: January 7, 2020
• 
  Review

  Open Access

  Androgen Receptor Splice Variant, AR-V7, as a Biomarker of Resistance to Androgen Axis-Targeted Therapies in Advanced Prostate Cancer

  Zhang et al.

  Published online: September 26, 2019

Most Cited (Previous 3 Years)